Coloplast (COLO) AGM 2022 summary
Event summary combining transcript, slides, and related documents.
AGM 2022 summary
23 Oct, 2026Opening remarks and agenda
Approved preparing the annual report, company announcements and AGM documents for internal use in English.
Approved changing the corporate language to English.
Board and executive committee updates
Lars Søren Rasmussen, Niels Peter Louis-Hansen, Annette Brüls, Carsten Hellmann, Jette Nygaard-Andersen and Marianne Wiinholt were re-elected to the Board.
After the AGM, Lars Søren Rasmussen was elected Chairman and Niels Peter Louis-Hansen Deputy Chairman; employee-elected Board members are Thomas Barfod, Nikolaj Kyhe Gundersen and Roland Vendelbo Pedersen.
Dividend announcements
Approved a year-end dividend of DKK 15 per nominal DKK 1 share; with the interim dividend of DKK 5, total FY 2021/22 dividends were DKK 20 per share.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Coloplast
- AGM approves DKK 9.00 dividend and governance changes.COLO
AGM 2016 - AGM approves DKK 11 dividend, share-issuance changes and new Board member.COLOAGM 2018
- AGM approved a DKK 17.00 per-share dividend and governance changes alongside Board re-elections.COLOAGM 2019
- AGM approves DKK 19.00 per share in dividends and elects a new Board member.COLOAGM 2021
- Strong organic growth and margin resilience driven by innovation and operational efficiency.COLOInvestor presentation
- 6% organic growth and strong cash flow, but Biologics hit by US reforms and Kerecis impairment.COLOQ3 25/26
- AGM approved a DKK 23.00 per-share dividend and elected Niels B. Christiansen to the Board.COLOAGM 2025
- 8% organic growth, a DKK 22 dividend, and four-platform strategy highlighted the AGM.COLOAGM 2024
- 8% organic growth and 27% EBIT margin before special items, FY guidance unchanged.COLOQ1 24/25